26 November 1996
08.00 - 9.00: |
Registration |
09.00 - 10.00: |
Opening session |
Welcome by the Deputy Secretary-General, FDA, Ministry of Public Health
Message from the Regional Director, WHO Regional Office for South-East Asia
Statement by Dr Jonathan Quick, Director, DAP/WHO/HQ
Introduction of participants
Nomination of Chairperson, Co-chairperson & Rapporteur
Background and objectives of the meeting (Dr Kin Shein, WHO/SEARO)
Administrative announcements:
(Ms. Suboonya Hutangkabodee, Director Technical Division, FDA)
10.00 - 10.30: |
Group photograph, followed by coffee/tea break |
10.30 - 12.00: |
Drug financing situation: 3 country presentations
(15 minutes/country) |
-Country participants:
* Thailand
* Nepal
* Myanmar
* Objectives of field visit: Dr Jonathan Quick
12.00 - 13.00: |
Lunch |
13.00: |
Depart hotel for field visit |
13.30 - 17.00: |
Field visit to: Soongnern Hospital
Health centre
Village drug fund
Debriefing at hospital |
27 November 1996, Wednesday
8.30 - 9.30: |
Review of major observations from first day |
9.30 - 10.00: |
Country presentation - Indonesia |
10.00 - 10.30: |
Coffee/tea break |
10.30 - 11.30: |
Drug financing strategies: Dr German Velasquez
(Presentation and discussions) |
11.30 - 12.30: |
Cost-sharing for drugs: Dr Petcharat Pongcharoensuk
(Presentation and discussions) |
12.30 - 13.30: |
Lunch |
13.30 - 15.30: |
Country priorities for workgroup action:
Dr Jonathan Quick, Dr German Velasquez
(Discussions and presentations, four groups) |
15.30 - 16.00: |
Coffee/tea break |
16.00 - 17.00: |
Monitoring for equity and quality: Dr Jonathan Quick
(Presentation and discussions) |
28 November 1996
8.30 - 10.00: |
Priorities for Working Group action
(Discussions, two work groups) |
10.00 - 10.30: |
Coffee/tea break |
10.30 - 12.30: |
Report from work group and discussions |
12.30 - 13.30: |
Lunch |
13.30 - 14.30: |
Country priorities for action (four work groups)
Health and drug financing indicators (four work groups) |
14.30 - 15.00: |
Presentation of country priorities for action |
15.00 - 15.15: |
Presentation of health and drug financing indicators:
Dr Jonathan Quick |
15.15 - 15.30: |
Evaluations and recommendations |
15 30 - 16.00: |
Next meeting, timing, venue and closing of meeting. |
Chargement en cours...
